Allergan has announced its Be the Difference philanthropic program supporting children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of age with upper limb spasticity. Botox Cosmetic is approved for three aesthetic indications, and Botox is approved for 11 therapeutic indications in the U.S. During the month of February, every Botox Cosmetic treatment recorded in Brilliant Distinctions, Allergan's loyalty reward program, will help Allergan contribute up to a total of $500,000 to foundations that help children across the country.
Read more at PR Newswire >>